Highest Quality
Pure Relief CBD Oil

 Quality Ingredients
 Excellent Customer Support
 Up To 5000MG!

Best Edibles
Pure Relief CBD Gummies

 Excellent Taste
  30MG of CBD per Gummie!
 30x In A Bag

Best for Pain
Pure Relief CBD Cream

 Pain Relief Cream
  Quick Absorbtion
 Fast Acting

The World Health Organization confirmed that CBD oil is safe for human consumption and should be legal (find out where to buy legal CBD oil for sale). In recommendations tabled by the Expert Committee on Drug Dependence (ECDD), a division of the world body, CBD oil was found to have loads of possible health benefits for healthy individuals and for those suffering from a number of diseases.

ECDD is mandated to advise the World Health Organization on ways to manage substances that have the potential to be harmful, addictive or those that create any form of dependence.

The report was pointed in its conclusion by stating that CBD does not possess any characteristics that would classify it as having the potential to be abused or to create dependence.

The ECDD report further lists the possible benefits of CBD in a clear indication of the positive nature of its findings. With millions of people using this hemp extract around the world, this report will have a huge impact on the perception that has persisted for decades classifying hemp alongside marijuana.

This report will guide WHO policy moving forward which will be in contrast to that of the United States. The latest announcements from the Drug Enforcement Administration, the U.S. agency mandated to combat the distribution and smuggling of illegal drugs, indicate that CBD remains an illegal substance under the Controlled Substances Act.

CBD or Cannabidiol is a cannabinoid constituent of the hemp plant. With more than 113 cannabinoids found in the hemp plant, CBD has been found to constitute 40% of the extract derived from hemp. Hemp belongs to the same cannabis family as marijuana. However, the main ingredient in marijuana is the psychoactive THC, which makes users feel “high.”

CBD consumption has been found to result in very few side effects.  Further evidence shows that CBD has significant anti-psychotic and anti-anxiety effects.  CBD’s proven antipsychotic properties have been used in treating schizophrenic patients. It has also been shown to effectively treat insomnia and depression (check out the best CBD oil for anxiety/depression). This has helped millions of patients regain normal sleep. 

CBD is known to be a powerful anti-inflammatory agent helping patients with chronic pain associated with conditions such as arthritis or fibromyalgia.  It also regulates gastric motility making it ideal to treat colitis and Crohn’s disease.

CBD is also a very powerful antioxidant. It is, therefore, an important antagonist of Parkinson’s disease and Alzheimer’s. CBD’s antioxidant properties also make it suitable for treating skin diseases. It has been found to prevent multiple sclerosis and alleviates the symptoms of those suffering from the condition.

In the wake of these findings by WHO, the hemp industry has vowed to take the battle against the DEA’s pronouncements to court for guidance. It is notable that consumers purchasing CBD products have not faced any challenges so far.

The WHO report may be a turning point for the world to accept CBD products such as bubble gum THC CBD into the mainstream market since they have been proven to be safe with multiple benefits.



The impact of ECDD’s report became apparent after the publication of the committee’s recommendations which covered several narcotic substances. While the report had been released earlier, it’s the recommendations that brought to the fore the huge effect this would have on the hemp industry. They raised concerns regarding the abuse potential of Carfentanil, for example, imposing stringent controls on its use and distribution.

CBD, on the other hand, was handed a clean bill of health with recommendations for further research to establish the full extent of its benefits.

With the new information, the committee indicated that there is no basis for the current classification of CBD as Schedule I drug. A full review of cannabidiol and other substances in the cannabis family was scheduled for mid-2018. This would give a clearer picture of the potential benefits of CBD and other related products such as Kratom CBD capsules.

The report was clear that research had established the nontoxic nature of CBD with minimal side effects for users. A specific example was the zero effect observed on the development of embryos.

The lack of abuse potential is not only encouraging for CBD proponents and enthusiasts but the mounting evidence of healing properties gives them the confidence to pursue the legalization route.

The report acknowledged the already developed clinical treatment of Epilepsy using CBD, which offers relief to symptoms associated with the condition in both children and adults. In fact, Epidiolex, whose medical use has been restricted to two rare forms of childhood epilepsy is a cannabidiol prescription drug approved in 2020 by the Food and Drug Administration (FDA), the regulatory agency in the United States.

The ECCD also noted that current research findings have established undisputed evidence of CBD’s impact in the treatment of epilepsy. The committee expressed optimism that CBD may be helpful in the treatment and management of other medical conditions. What is required is dedicated research to establish its efficacy and how widely it can be used.

The committee further noted that CBD’s potency may be applicable in the treatment of quite a number of conditions based on its characteristics. The substance has anti-inflammatory, analgesic, anxiolytic, anti-asthmatic, anti-tumor, neuroprotective, antiepileptic and antipsychotic properties. Further, CBD has the ability to control the flow of oxygen giving it potential to manage hypoxia-ischemia.



The ECCD is an important division of WHO because of its advisory role. The recommendations by this committee determine which drugs are classified in the Single Convention on Narcotic Drugs. This convention lists substances which are considered dangerous and therefore illegal and the ones that have exceptional medical uses.

Although ECCD recommended further research to determine which other areas CBD can be useful, declaring the substance safe is a first step on the path to mainstream use. The situation is promising across the world including in the sporting field. The World Anti-Doping Agency has given athletes the green light to use CBD beginning this year.

The substance, which was previously banned, can now be used in fitness regimes that put emphasis on increasing muscle tissue. This is primarily due to the anti-catabolic properties of CBD. This has made CBD a revolutionary supplement for professional athletes and fitness enthusiasts keen on relieving pain, fighting disease and enhancing muscle tissue. 

In the U.S. CBD still faces a hurdle from the authorities. The FDA continues to classify it as a Schedule I drug keeping it out of mainstream use. With the scientific evidence coming from the WHO, it is hoped that the United States will re-look at the data and open the route towards legalization.

CBD’s characteristics show the potential to treat numerous conditions including Alzheimer’s, Parkinson’s disease, multiple sclerosis, Huntington’s disease, Hypoxia-ischemia, psychosis, anxiety, depression, cancer, nausea, inflammatory diseases, rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease, cardiovascular diseases, and diabetic complications.

Its worldwide acceptance will open the way for creative uses in multiple sectors. The health sector may seem to be the greatest beneficiary but as CBD Oil Adviser have documented athletes will be able to enhance their performance while other sectors such as construction, paper, and food industries can utilize CBD in their products.

4.9/513 ratings